(Q38083431)

28 August 2017

title

Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know (English)

1 reference

28 August 2017

1 reference

hepatocellular carcinoma

1 reference

Yun Hwan Kim

1

1 reference

28 August 2017

Do Young Kim

series ordinal

2

1 reference

28 August 2017

publication date

20 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

84 Suppl 1

1 reference

28 August 2017

page(s)

34-39

1 reference

Chemoembolization in patients with hepatocellular carcinoma

28 August 2017

cites work

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

21 January 2018

1 reference

Radioembolization for hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations.

21 January 2018

1 reference

Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review

21 January 2018

1 reference

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

21 January 2018

1 reference

Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

21 January 2018

1 reference

Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis

21 January 2018

1 reference

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

21 January 2018

1 reference

Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review.

21 January 2018

1 reference

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

21 January 2018

1 reference

Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors

21 January 2018

1 reference

Biliary sequelae following radioembolization with Yttrium-90 microspheres

21 January 2018

1 reference

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia

21 January 2018

1 reference

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis

21 January 2018

1 reference

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

21 January 2018

1 reference

Dose distribution following selective internal radiation therapy

21 January 2018

1 reference

Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.

21 January 2018

1 reference

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

21 January 2018

1 reference

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000345887

1 reference

28 August 2017

1 reference